Our core competence has always been in state-of-the-art development and manufacturing infrastructure. We have four R&D divisions dedicated to process research, drug discovery and development, pharmaceutical research and biotechnology. These research facilities are in the vanguard of creating generic product pipelines, proprietary discovery pipelines, novel processes and formulations, each aimed at building valuable intellectual property. From modeling of a new drug candidate in silico to its validation in an animal model, we are capable of conducting all research activities in-house. Sophisticated equipment and modern bioinformatics provide an edge to Orchid's drug discovery activities. The National Good Laboratory Practices (GLP) Monitoring Authority of India, aligned to OECD Principles of GLP has also certified our R&D facilities for GLP compliance.
Our end-to-end connected infrastructure, which enables complete value-chain integration, remains a key driver of our growth in the diverse and differentiated arenas of generic and discovery research, encompassing the entire pharmaceutical spectrum.